Received May 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (BEXSERO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | — | — |
Previous vaccination schedule was being used after October 2024; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate schedule of vaccine administered in unspecified number of patients who received Men B NVS (Bexsero) for prophylaxis. On an unknown date, the patient received Bexsero. On an unknown date, an unknown time after receiving Bexsero, the patient experienced inappropriate schedule of vaccine administered (Verbatim: Previous vaccination schedule was being used after October 2024). The outcome of the inappropriate schedule of vaccine administered was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 09-MAY-2025 The Vaccine Administration Facility was the same as Primary Reporter. A medical assistant called in to request data about the vaccination series and different changes that had been done to the schedule. They mentioned that they were receiving lots with the previous Prescribing information. They mentioned that every pediatric patient from October 24th, 2024 onward until today had received the previous schedule, without specifying number, age, gender or status which led to inappropriate schedule of vaccine administered. The reporter declined any type of follow up.